ArticleEndocrine connections2025
Characteristics, management and outcomes of patients with hyponatraemia presenting to an Irish tertiary hospital.
Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Furosemide plus oral sodium chloride for syndrome of inappropriate antidiuresis after fluid restriction failure.Clinical kidney journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Hyponatraemia is the most common electrolyte abnormality in clinical practice and is associated with increased in-hospital mortality and length of stay (LOS). The aims of this study were to evaluate the prevalence of hyponatraemia in adult medical inpatients, compliance with consensus guidelines regarding evaluation and management of hyponatraemia, LOS and mortality. Design: This was a retrospective single-centre observational study conducted in a tertiary-level Irish hospital. Methods: Adult patients admitted under the medical services over a 2-month period with a serum sodium (sNa) <135 mmol/L were included. Patients were classified according to nadir sNa during their admission; mild, moderate and severe hyponatraemia were defined as an sNa between 130 and 134 mmol/L, 125-129 mmol/L and <125 mmol/L respectively. Clinical information was gathered retrospectively. Results: 486 patient episodes of hyponatraemia were included. The prevalence of hyponatraemia was 32.9%. The median age was 78 (min-max: 16-100) years and 239 (49.0%) were female. The median nadir sNa was 132 (min-max: 105-143) mmol/L. Eighty-seven (17.9%) and 48 (9.9%) patients had moderate and severe hyponatraemia. In cases of moderate and severe hyponatraemia, the most common cause of hyponatraemia was hypovolaemia (n = 33, 24.4%). Ninety-one patients (67.4%) with moderate and severe hyponatraemia had active treatment of hyponatraemia and 33 (24.4%) had input from a specialist service. The mean LOS was 15.0 (±22.5), 19.3 (±21.7) and 21.2 (±45.5) (P = 0.01) days in mild, moderate and severe hyponatraemia, respectively. Overall inpatient mortality was 7.0% (n = 34). Conclusions: Hyponatraemia is often incompletely investigated and suboptimally managed, with insufficient input from specialist services sought in a large tertiary hospital. Hyponatraemia therefore represents a potential intervention target to reduce inpatient morbidity, mortality and healthcare costs. Significance statement: Hyponatraemia is a common electrolyte disturbance among hospitalised patients, associated with increased morbidity, mortality and healthcare costs. In this retrospective study of medical inpatients at an Irish tertiary hospital, we found a high prevalence (32.9%) of hyponatraemia, with significant gaps in its investigation, diagnosis and management. Hypovolaemic hyponatraemia was the most frequent aetiology in moderate-to-severe cases, yet diagnostic tools and volume assessments were often underutilised. Suboptimal treatment approaches, including low rates of fluid restriction for SIADH, were evident. Our findings highlight the need for improved education, protocolised care and early specialist involvement to enhance outcomes. These results are generalisable to other centres, emphasising hyponatraemia as a key target for improving inpatient care and reducing healthcare costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.